Allergan Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (68)

Latest Posts

About This Stock More About This Stock
Wall Street's Top Stories For Tuesday, Jan. 29th
Article By: The Fly
Tuesday, January 29, 2019 4:08 PM EST
Stocks have mixed day as investors await Apple earnings.
In this article: AGN, EAT, GME, MMM, PCG, PFE, VZ, AAPL, SANM, WWD, FMCC, FNMA, SQ, OCX
Read
How Trump's Policies Moved Stocks - Dec. 23
Article By: The Fly
Sunday, December 23, 2018 10:40 PM EST
Trump accuses Facebook, Twitter, and Google of being "biased;" White House blocks tax break for alcohol companies.
In this article: BF-A, FB, GOOGL, GOOG, TWTR, DEO, STZ, BF-B, AGN, AZN, NVS
Read
5 Drug/Biotech Stocks Likely To Beat Q3 Earnings Estimates
Article By: Zacks Investment Research
Sunday, October 28, 2018 2:00 PM EST
There are a number of drug/biotech companies poised to surpass third-quarter estimates. However, given the large number of drug/biotech firms, the task of selecting stocks with possibilities to beat could appear quite daunting.
In this article: REGN, AGN, AMGN, ALNY, AMAG
Read
Allergan Says Study Of Higher Doses Of BOTOX Meets Primary Endpoint
Article By: The Fly
Friday, September 14, 2018 8:09 PM EST
Allergan announced clinical study results of higher doses of BOTOX Cosmetic compared to BOTOX Cosmetic 20 unit dose at week 24 in patients with moderate to severe glabellar lines.
In this article: AGN
Read
Allergan Upgraded To Buy From Neutral At Mizuho
Article By: The Fly
Friday, August 3, 2018 9:31 AM EST
Mizuho analyst Irina Koffler upgraded Allergan to Buy and raised her price target for the shares to $210 from $194.
In this article: AGN
Read

PARTNER HEADLINES

Latest Tweets for $AGN

No tweets yet!

$AGN

Patent Losses Could Sink Allergan
Dean Gilmore 2/5/2018 2:37:30 PM

Look at where $AGN was a year ago. It has lost a chunk of it's value already. This news won't help.

Patent Losses Could Sink Allergan
Alpha Stockman 2/5/2018 2:26:42 PM

These hits all hurt #Allergan's bottom line but aren't it's cash cows like #Botox which still does very well for the company and will only only generate even more revenue over time. $AGN

Patent Losses Could Sink Allergan
Ayelet Wolf 2/5/2018 2:22:51 PM

This news sounds catastrophic to me. Why isn't #Allergan tanking? $AGN

Valeant Edges Up 15% After Announcing That It Will Acquire Salix
Terry Caruso 2/24/2015 8:20:44 PM

You said the company tried to acquire Allergan but the deal fell through because Valeant didn't like it's large R&D program. If true, why did it try to acquire $AGN in the first place?

1 to 4 of 4 comments